Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the national comprehensive cancer network

Journal of Clinical Oncology

Volumn 26, Issue 31, 2008, Pages 5107-5112

  LaCasce, Ann S ^a   Kho, Michelle E ^b   Friedberg, Jonathan W ^b   Niland, Joyce C ^b   Abel, Gregory A ^b   Rodriguez, Maria Alma ^b   Czuczman, Myron S ^b   Millenson, Michael M ^b   Zelenetz, Andrew D ^b   Weeks, Jane C ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CANCER CENTER; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER THERAPY; DATA BASE; FOLLICULAR LYMPHOMA; GENERAL PATHOLOGY; HUMAN; NONHODGKIN LYMPHOMA; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; WORLD HEALTH ORGANIZATION;

CANCER CARE FACILITIES; HUMANS; LYMPHOMA, NON-HODGKIN; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; REGISTRIES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; UNITED STATES;

EID: 55549088215     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.4061     Document Type: Article

References (9)

1. Harris NL, Jaffe ES, Diebold J, et al: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10:1419-1432, 1999
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: The Non-Hodgkin's Lymphoma Classification Project. Blood 89:3909-3918, 1997
3. Classification of non-Hodgkin's lymphomas: Reproducibility of major classification systems - NCI non-Hodgkin's Classification Project Writing Committee. Cancer 55:91-95, 1985
4. Dick F, VanLier S, Banks P, et al: Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: Agreement between reported diagnoses and a panel of experienced pathologists. J Natl Cancer Inst 78:1137-1144, 1987
5. Wolf BC, Gilchrist KW, Mann RB, et al: Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials: The Eastern Cooperative Oncology Group experience. Cancer 62:1301-1305, 1988
6. Whitcomb CC, Crissman JD, Flint A, et al: Reproducibility in morphologic classification of non-Hodgkin's lymphomas using the Lukes-Collins system: The Southeastern Cancer Study Group experience. Am J Clin Pathol 82:383-388, 1984
7. Ezdinli EZ, Costello W, Wasser LP, et al: Eastern Cooperative Oncology Group experience with the Rappaport classification of non-Hodgkin's lymphomas. Cancer 43:544-550, 1979
8. Kukreti V, Patterson B, Callum J, et al: Pathology the gold standard: A retrospective analysis of discordant "second-opinion" lymphoma pathology and its impact on patient care. Blood 108:348, 2006 (abstr 348)
9. Morton LM, Wang SS, Devesa SS, et al: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107:265-276, 2006